[HTML][HTML] IL-10-producing regulatory B cells (B10 cells) in autoimmune disease

I Kalampokis, A Yoshizaki, TF Tedder - Arthritis research & therapy, 2013 - Springer
B cell abnormalities contribute to the development and progress of autoimmune disease.Traditionally,
the role of B cells in autoimmune disease was thought to be predominantly limited …

Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions

A Yoshizaki, T Miyagaki, DJ DiLillo, T Matsushita… - Nature, 2012 - nature.com
B cells regulate immune responses by producing antigen-specific antibodies 1 . However,
specific B-cell subsets can also negatively regulate T-cell immune responses, and have been …

Pathogenic roles of B lymphocytes in systemic sclerosis

A Yoshizaki - Immunology Letters, 2018 - Elsevier
Systemic sclerosis (SSc) is a collagen disease characterized by autoimmunity and excessive
extracellular matrix deposition in the skin and visceral organs. Although the pathogenic …

[HTML][HTML] New era in systemic sclerosis treatment: recently approved therapeutics

…, A Yoshizaki-Ogawa, S Sato, A Yoshizaki - Journal of Clinical …, 2022 - mdpi.com
Systemic sclerosis (SSc) is a chronic autoimmune disease with a poor prognosis. Among the
various complications of SSc, treatment options for the fibrotic lesions, skin sclerosis, and …

Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors

…, K Yamazumi, Y Yakata, A Yoshizaki… - Journal of clinical …, 2005 - jcp.bmj.com
Background: The signal transducer and activator of transcription 3 (STAT3) is a key signalling
molecule implicated in the regulation of growth and malignant transformation. Constitutive …

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function

DJ DiLillo, JB Weinberg, A Yoshizaki, M Horikawa… - Leukemia, 2013 - nature.com
Chronic lymphocytic leukemia (CLL) can be immunosuppressive in humans and mice, and
CLL cells share multiple phenotypic markers with regulatory B cells that are competent to …

[HTML][HTML] IL-10–producing regulatory B10 cells inhibit intestinal injury in a mouse model

K Yanaba, A Yoshizaki, Y Asano, T Kadono… - The American journal of …, 2011 - Elsevier
B cells mediate multiple functions that influence immune and inflammatory responses. In
mice, the addition of dextran sulfate sodium (DSS) to drinking water leads to immediate …

Treatment with rapamycin prevents fibrosis in tight‐skin and bleomycin‐induced mouse models of systemic sclerosis

A Yoshizaki, K Yanaba, A Yoshizaki… - Arthritis & …, 2010 - Wiley Online Library
Objective Rapamycin, a novel macrolide immunosuppressive drug, is increasingly used as
an agent for posttransplant immunosuppression and treatment of autoimmune disease. The …

Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis

K Yanaba, A Yoshizaki, Y Asano, T Kadono… - Clinical rheumatology, 2011 - Springer
To determine serum interleukin-33 (IL-33) levels and their associations with clinical parameters
in patients with systemic sclerosis (SSc). Serum IL-33 levels were examined by enzyme-…

Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial

S Ebata, A Yoshizaki, K Oba, K Kashiwabara… - The Lancet …, 2021 - thelancet.com
Background Systemic sclerosis is a connective tissue disease characterised by multiorgan
fibrosis with an autoimmune background and poor prognosis. Although a few drugs have …